コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 identify novel targets for treatment of this blinding disease.
2 fic therapeutic targets in treatment of this blinding disease.
3 ated macular degeneration, which is a common blinding disease.
4 photoswitches to restore visual function in blinding disease.
5 Primary open-angle glaucoma (POAG) is a blinding disease.
6 erapeutic candidates for the mutation-caused blinding disease.
7 (LCA1), an autosomal recessive human retinal blinding disease.
8 is necessary to achieve elimination of this blinding disease.
9 reinfection, known risk factors which drive blinding disease.
10 Paget disease of bone, and glaucoma, a major blinding disease.
11 PE), the two layers that are damaged in this blinding disease.
12 to the most common form of glaucoma, a major blinding disease.
13 support neuroprotective strategies for this blinding disease.
14 d and targeted treatments to ameliorate this blinding disease.
15 bute to the development of glaucoma, a major blinding disease.
16 therapeutic potential for prevention of this blinding disease.
17 argeted for therapeutic intervention in this blinding disease.
18 ent of miRNA-targeted therapeutics to combat blinding diseases.
19 poor visual acuity were less aware of these blinding diseases.
20 on restoration in patients with degenerative blinding diseases.
21 hysiological vascular development and common blinding diseases.
22 late-stage intervention in the management of blinding diseases.
23 r restoring retinal function in degenerative blinding diseases.
24 ssociated disorders, including several human blinding diseases.
25 ially promising agents for the fight against blinding diseases.
26 of its regression in humans leads to several blinding diseases.
27 n and expand their indications to many other blinding diseases.
28 s the basis for vision loss in several major blinding diseases.
29 severe vision impairment for many prevalent blinding diseases.
30 acranial hypertension (IIH) is a potentially blinding disease and may require surgical management whe
31 macular degeneration (AMD) is a progressive blinding disease and represents the leading cause of vis
32 vitreoretinopathy (PVR) is a nonneovascular blinding disease and the leading cause for failure in su
34 nd facilitate global intervention methods in blinding diseases and other neurodegenerative disorders.
35 ons (IPDs), a group of incurable progressive blinding diseases, are caused by mutations in more than
36 degeneration, retinitis pigmentosa and other blinding diseases, as well as the ROI-induced death of o
37 Proliferative vitreoretinopathy (PVR) is a blinding disease associated with rhegmatogenous retinal
38 This might open new treatment options in blinding diseases associated with corneal edema and tran
39 Twelve percent of American patients with the blinding disease autosomal dominant retinitis pigmentosa
40 r cells, are a major cause of the hereditary-blinding disease, autosomal dominant retinitis pigmentos
41 ne of the most prevalent causes of the human blinding disease, autosomal dominant retinitis pigmentos
43 he human RPE65 gene cause a severe recessive blinding disease called Leber's congenital amaurosis.
44 the gene encoding this protein can lead to a blinding disease called retinitis pigmentosa, which is i
46 ng them, 99 % were aware that diabetes was a blinding disease caused by DR.11.5 % of the subjects wer
47 of recessive Stargardt macular dystrophy, a blinding disease caused by dysfunction or loss of the AB
48 ive Stargardt maculopathy is another central blinding disease caused by mutations in the gene for ABC
49 itis pigmentosa (RP) is a group of inherited blinding diseases caused by mutations in multiple genes
51 macular degeneration (AMD) are degenerative blinding diseases caused by the death of rods and cones,
52 d age-related macular degeneration (AMD) are blinding diseases caused by the degeneration of rods and
53 l corneal dystrophy (FECD) is a progressive, blinding disease characterized by corneal endothelial (C
54 neuropathy (LHON) is a maternally inherited blinding disease characterized by degeneration of retina
57 Retinitis pigmentosa (RP) is an inherited blinding disease characterized by progressive loss of re
58 in are two genes linked to glaucoma, a major blinding disease characterized by progressive loss of re
59 Importance: HSK in humans is a potentially blinding disease characterized by recurrent inflammation
60 degeneration (AMD) is a common, potentially blinding disease characterized by the presence of extrac
62 ged cause of retinal degeneration in genetic blinding diseases (e.g., Stargardt) and a possible etiol
63 erity from minor transient discomfort to the blinding disease herpes stromal keratitis, yet most pati
67 RPE) gene RPE65 are associated with multiple blinding diseases including Leber's Congenital Amaurosis
69 human diseases, ranging from the devastating blinding disease Leber congenital amaurosis (LCA) to Sen
71 essive Stargardt's macular degeneration is a blinding disease of children caused by mutations in the
72 gardt's macular degeneration is an inherited blinding disease of children caused by mutations in the
73 Mutations in the human RPE65 gene cause a blinding disease of infancy called Leber congenital amau
74 ge-related macular degeneration, a prevalent blinding disease of the elderly, is strongly associated
77 nal ganglion cells is the final end point in blinding diseases of the optic nerve such as glaucoma.
79 r preventing the loss of vision because most blinding diseases originate in cellular components of th
80 the retina and is a major feature of leading blinding diseases, particularly diabetic retinopathy.
81 Retinitis pigmentosa is a heritable group of blinding diseases resulting from loss of photoreceptors,
84 ents that have the potential to treat common blinding diseases such as age-related macular degenerati
85 play a role in retinal damage in a number of blinding diseases such as glaucoma and diabetic retinopa
87 al of pathologic angiogenesis that occurs in blinding diseases such as proliferative diabetic retinop
88 of retinal degeneration in animal models of blinding diseases such as retinitis pigmentosa (RP) and
90 s, including certain cancers and potentially blinding diseases, such as age-related macular degenerat
91 e understanding of the molecular pathways of blinding diseases, such as diabetic retinopathy and glau
92 rosis (LCA) encompasses a set of early-onset blinding diseases that are characterized by vision loss,
93 s a broad-spectrum therapeutic treatment for blinding diseases, the target cells of exogenous CNTF an
94 for sexually transmitted infections and the blinding disease trachoma, which affect hundreds of mill
96 eber congenital amaurosis (LCA), a childhood blinding disease with early-onset retinal degeneration a
97 ng protein-like1 (AIPL1) are associated with blinding diseases with a wide range of severity in human
100 genesis or failure of treatment of all major blinding diseases, with postoperative wound healing resp
102 the complement system is a feature of these blinding diseases, yet how the RPE combats complement at
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。